Therapeutics for Leukemia: Targeting Cancer-associated Glycans The inception of cancer immunotherapy could be traced back to the 19th century when the 'Father of Cancer Immunotherapy', William Coley, successfully led spontaneous regression of tumors by developing erysipelas with the injection of Coley's toxins into cancer patients. Different from cytotoxic chemotherapy, cancer immunotherapy allows targeted therapies, which fight against cancer by...
0 Shares
217 Views
0 Reviews